Q1 EPS Forecast for iRhythm Technologies Lifted by Analyst

iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) - William Blair upped their Q1 2025 earnings per share (EPS) estimates for shares of iRhythm Technologies in a report issued on Thursday, October 31st. William Blair analyst M. Kaczor now forecasts that the company will post earnings of ($0.65) per share for the quarter, up from their prior estimate of ($0.92). The consensus estimate for iRhythm Technologies' current full-year earnings is ($2.66) per share. William Blair also issued estimates for iRhythm Technologies' Q2 2025 earnings at ($0.42) EPS, Q3 2025 earnings at ($0.40) EPS and Q4 2025 earnings at ($0.29) EPS.

Several other research firms have also weighed in on IRTC. StockNews.com lowered iRhythm Technologies from a "hold" rating to a "sell" rating in a research report on Friday, September 27th. Robert W. Baird dropped their price target on iRhythm Technologies from $100.00 to $79.00 and set an "outperform" rating on the stock in a research note on Friday. Canaccord Genuity Group increased their price target on iRhythm Technologies from $122.00 to $137.00 and gave the stock a "buy" rating in a report on Wednesday, September 25th. Citigroup decreased their price target on shares of iRhythm Technologies from $135.00 to $110.00 and set a "buy" rating for the company in a research note on Thursday, August 22nd. Finally, Needham & Company LLC cut their target price on iRhythm Technologies from $119.00 to $96.00 and set a "buy" rating on the stock in a report on Thursday. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $108.50.

iRhythm Technologies Trading Up 8.5 %

IRTC stock traded up $6.40 during midday trading on Monday, hitting $81.44. The stock had a trading volume of 836,836 shares, compared to its average volume of 472,016. The company has a current ratio of 6.27, a quick ratio of 6.76 and a debt-to-equity ratio of 9.00. The firm has a market cap of $2.55 billion, a P/E ratio of -16.51 and a beta of 1.23. The business has a fifty day moving average price of $69.24 and a two-hundred day moving average price of $84.85. iRhythm Technologies has a 1-year low of $55.92 and a 1-year high of $124.11.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.71). iRhythm Technologies had a negative return on equity of 120.86% and a negative net margin of 26.90%. The firm had revenue of $147.54 million during the quarter, compared to analyst estimates of $146.69 million. During the same quarter last year, the firm posted ($0.89) EPS. The firm's revenue for the quarter was up 18.4% on a year-over-year basis.

Insider Transactions at iRhythm Technologies

In other news, CFO Brice Bobzien sold 1,372 shares of the company's stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $70.34, for a total value of $96,506.48. Following the completion of the transaction, the chief financial officer now directly owns 24,428 shares of the company's stock, valued at $1,718,265.52. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 0.68% of the company's stock.

Institutional Investors Weigh In On iRhythm Technologies

A number of hedge funds have recently made changes to their positions in the business. Headlands Technologies LLC increased its holdings in iRhythm Technologies by 10,650.0% during the first quarter. Headlands Technologies LLC now owns 430 shares of the company's stock worth $50,000 after buying an additional 426 shares during the last quarter. Nisa Investment Advisors LLC grew its position in shares of iRhythm Technologies by 79.6% during the 2nd quarter. Nisa Investment Advisors LLC now owns 625 shares of the company's stock valued at $67,000 after acquiring an additional 277 shares during the period. SG Americas Securities LLC purchased a new stake in shares of iRhythm Technologies during the 1st quarter worth approximately $126,000. Russell Investments Group Ltd. raised its holdings in shares of iRhythm Technologies by 79,700.0% in the 1st quarter. Russell Investments Group Ltd. now owns 1,596 shares of the company's stock worth $185,000 after purchasing an additional 1,594 shares during the period. Finally, nVerses Capital LLC lifted its stake in iRhythm Technologies by 400.0% in the third quarter. nVerses Capital LLC now owns 2,000 shares of the company's stock valued at $148,000 after purchasing an additional 1,600 shares during the last quarter.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.